5-87419023-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000644559.1(ENSG00000285190):​n.720+5962G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.477 in 151,374 control chromosomes in the GnomAD database, including 17,404 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.48 ( 17404 hom., cov: 29)

Consequence

ENSG00000285190
ENST00000644559.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0340

Publications

4 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000644559.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.561 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000644559.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000285190
ENST00000644559.1
n.720+5962G>A
intron
N/A
ENSG00000285190
ENST00000797782.1
n.684+5962G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.476
AC:
72073
AN:
151256
Hom.:
17382
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.567
Gnomad AMI
AF:
0.454
Gnomad AMR
AF:
0.420
Gnomad ASJ
AF:
0.461
Gnomad EAS
AF:
0.509
Gnomad SAS
AF:
0.477
Gnomad FIN
AF:
0.454
Gnomad MID
AF:
0.583
Gnomad NFE
AF:
0.435
Gnomad OTH
AF:
0.494
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.477
AC:
72138
AN:
151374
Hom.:
17404
Cov.:
29
AF XY:
0.477
AC XY:
35274
AN XY:
73876
show subpopulations
African (AFR)
AF:
0.567
AC:
23418
AN:
41272
American (AMR)
AF:
0.419
AC:
6370
AN:
15192
Ashkenazi Jewish (ASJ)
AF:
0.461
AC:
1598
AN:
3468
East Asian (EAS)
AF:
0.508
AC:
2604
AN:
5130
South Asian (SAS)
AF:
0.479
AC:
2298
AN:
4794
European-Finnish (FIN)
AF:
0.454
AC:
4716
AN:
10386
Middle Eastern (MID)
AF:
0.572
AC:
167
AN:
292
European-Non Finnish (NFE)
AF:
0.435
AC:
29517
AN:
67834
Other (OTH)
AF:
0.495
AC:
1037
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1879
3759
5638
7518
9397
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
662
1324
1986
2648
3310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.447
Hom.:
30192
Bravo
AF:
0.480
Asia WGS
AF:
0.489
AC:
1699
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.84
DANN
Benign
0.36
PhyloP100
0.034

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10065575;
hg19: chr5-86714840;
COSMIC: COSV63185556;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.